Malin Corporation gets €70m investment from EIB Dublin based life sciences company Malin Corporation has secured a €70m, seven year debt facility from the European Investment Bank. Business • 23 Jun 16
Malin Corporation gets €70m investment from EIB Dublin based life sciences company Malin Corporation has secured a €70m, seven year debt facility from the European Investment Bank. Business • 23 Jun 16
US drugmaker Perrigo to buy Elan for $8.6 billion US generic drugmaker Perrigo has agreed to buy Dublin based drug company Elan for $8.6 billion. Business • 29 Jul 13
US drugmaker Perrigo to buy Elan for $8.6 billion US generic drugmaker Perrigo has agreed to buy Dublin based drug company Elan for $8.6 billion. Business • 29 Jul 13
Elan has 'Plan B' if shareholders reject deals Elan said it will lay out an alternative strategy if shareholders reject a string of planned deals. Business • 30 May 13
Elan has 'Plan B' if shareholders reject deals Elan said it will lay out an alternative strategy if shareholders reject a string of planned deals. Business • 30 May 13
Royalty Pharma increases offer for Elan Royalty Pharma has revised its bid for Irish pharmaceutical company Elan, with an all-cash offer of $12.50 per share compared to the $11.25 offered previously. Business • 20 May 13
Royalty Pharma increases offer for Elan Royalty Pharma has revised its bid for Irish pharmaceutical company Elan, with an all-cash offer of $12.50 per share compared to the $11.25 offered previously. Business • 20 May 13
Elan's Q3 revenues up 10%, but losses mount Elan has reported third quarter revenues of $306.6m for the three months to the end of September. Business • 24 Oct 12
Elan's Q3 revenues up 10%, but losses mount Elan has reported third quarter revenues of $306.6m for the three months to the end of September. Business • 24 Oct 12
Elan to spin off Neotope Biosciences unit The board of Elan has approved the spin-off of its discovery science and Neotope Biosciences from the company, in a move which makes Elan immediately profitable. Business • 13 Aug 12
Elan to spin off Neotope Biosciences unit The board of Elan has approved the spin-off of its discovery science and Neotope Biosciences from the company, in a move which makes Elan immediately profitable. Business • 13 Aug 12
Élan reports $60.3m loss in first half of 2012 Pharma group Élan has reported a net loss of $60.3m in the first half of 2012. Business • 25 Jul 12
Élan reports $60.3m loss in first half of 2012 Pharma group Élan has reported a net loss of $60.3m in the first half of 2012. Business • 25 Jul 12
